ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results.

Naval G Daver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.